ICICI Prudential Healthcare Fund Growth is a Sector - Healthcare mutual fund scheme from ICICI Prudential Asset Management Co Ltd. The fund was launched on 12 July 2018 and is managed by Sharmila D'Silva and Dharmesh Kakkad. As of 15 October 2026, the fund has an AUM of ₹6,861.20 Cr and its latest NAV is ₹41.28. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹5,000.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Sun Pharmaceuticals Industries Ltd, Dr Reddy's Laboratories Ltd, Cipla Ltd, Biocon Ltd, and Mankind Pharma Ltd. The fund has delivered 3.0% returns over the last 1 year, 19.4% annualised returns over 3 years, 14.0% annualised returns over 5 years, and 18.7% annualised returns since inception.
ICICI Prudential Healthcare Fund Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






